10.00
price up icon2.99%   0.29
after-market After Hours: 10.55 0.55 +5.50%
loading
Atara Biotherapeutics Inc stock is traded at $10.00, with a volume of 112.20K. It is up +2.99% in the last 24 hours and up +24.69% over the past month. Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
See More
Previous Close:
$9.71
Open:
$9.8
24h Volume:
112.20K
Relative Volume:
2.06
Market Cap:
$59.61M
Revenue:
$100.44M
Net Income/Loss:
$-133.16M
P/E Ratio:
-0.3882
EPS:
-25.76
Net Cash Flow:
$-94.85M
1W Performance:
+8.34%
1M Performance:
+24.69%
6M Performance:
+52.21%
1Y Performance:
-4.81%
1-Day Range:
Value
$9.7764
$10.99
1-Week Range:
Value
$8.53
$10.99
52-Week Range:
Value
$5.005
$18.70

Atara Biotherapeutics Inc Stock (ATRA) Company Profile

Name
Name
Atara Biotherapeutics Inc
Name
Phone
805-623-4211
Name
Address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
Name
Employee
89
Name
Twitter
@Atarabio
Name
Next Earnings Date
2024-11-18
Name
Latest SEC Filings
Name
ATRA's Discussions on Twitter

Compare ATRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ATRA
Atara Biotherapeutics Inc
10.00 55.02M 100.44M -133.16M -94.85M -25.76
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.81 120.40B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.52 61.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.53 41.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.59 34.29B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.55 27.09B 3.81B -644.79M -669.77M -6.24

Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-09-23 Downgrade Evercore ISI Outperform → In-line
Nov-09-23 Downgrade H.C. Wainwright Buy → Neutral
Nov-09-23 Downgrade Mizuho Buy → Neutral
Jul-20-22 Downgrade Citigroup Neutral → Sell
Jul-13-22 Downgrade JP Morgan Overweight → Neutral
Jul-13-22 Downgrade Stifel Buy → Hold
May-10-22 Downgrade Citigroup Buy → Neutral
May-13-21 Upgrade JP Morgan Neutral → Overweight
Dec-09-20 Downgrade Citigroup Buy → Neutral
Dec-08-20 Reiterated H.C. Wainwright Buy
Nov-10-20 Reiterated H.C. Wainwright Buy
Jun-30-20 Initiated Evercore ISI Outperform
Jun-15-20 Initiated H.C. Wainwright Buy
Apr-23-20 Upgrade Citigroup Neutral → Buy
Nov-08-19 Downgrade JP Morgan Overweight → Neutral
Sep-27-19 Downgrade Goldman Neutral → Sell
Sep-16-19 Downgrade Jefferies Buy → Hold
Jun-04-19 Upgrade Citigroup Sell → Neutral
May-30-19 Initiated ROTH Capital Buy
May-23-19 Initiated Stifel Buy
Jan-23-19 Initiated Mizuho Buy
Apr-10-18 Initiated JP Morgan Overweight
Mar-16-18 Initiated Guggenheim Neutral
Mar-05-18 Reiterated Jefferies Buy
Feb-28-18 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Feb-15-18 Downgrade Citigroup Neutral → Sell
Jan-03-18 Upgrade Citigroup Sell → Neutral
Oct-06-17 Resumed Goldman Neutral
View All

Atara Biotherapeutics Inc Stock (ATRA) Latest News

pulisher
Jul 19, 2025

Is Atara Biotherapeutics Inc. a good long term investmentTriple-digit wealth increases - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Atara Biotherapeutics Inc. stock priceOutstanding capital appreciation - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about Atara Biotherapeutics Inc. stockUnprecedented profits - Jammu Links News

Jul 19, 2025
pulisher
Jul 15, 2025

How Atara Biotherapeutics Inc. stock performs during market volatilityDaily Breakout Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Atara Biotherapeutics Inc. stock attracts strong analyst attentionFree Discussion Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atara Biotherapeutics Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Major FDA Development: Pierre Fabre Assumes Control of Atara's EBV Cell Therapy Program After BLA Resubmission - Stock Titan

Jul 15, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics Resubmits BLA for Tab-cel to FDA - TipRanks

Jul 14, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®) | ATRA Stock News - GuruFocus

Jul 14, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics provides regulatory and business updates on tabelecleucel (tab-cel) - MarketScreener

Jul 14, 2025
pulisher
Jul 14, 2025

Atara resubmits tabelecleucel BLA to FDA for EBV-positive PTLD By Investing.com - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel - Business Wire

Jul 14, 2025
pulisher
Jul 10, 2025

(ATRA) Technical Data - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 08, 2025

We Might See A Profit From Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Soon - simplywall.st

Jul 08, 2025
pulisher
Jun 30, 2025

Atara Biotherapeutics, Inc.(NasdaqGS: ATRA) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 11, 2025

Atara Biotherapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 06, 2025

Long Term Trading Analysis for (ATRA) - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Purchases New Position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Short Interest Update - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Bank of America Corp DE Acquires 1,543 Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Redmile Group, LLC's Strategic Acquisition in Atara Biotherapeutics Inc - GuruFocus

May 29, 2025
pulisher
May 28, 2025

Here's Why You Should Consider Buying Atara Biotherapeutics Stock - Barchart.com

May 28, 2025
pulisher
May 28, 2025

Biotech Pioneer Pascal Touchon Joins CDR-Life Board: Former Atara CEO to Drive T Cell Platform Innovation - Stock Titan

May 28, 2025
pulisher
May 27, 2025

(ATRA) Trading Advice - news.stocktradersdaily.com

May 27, 2025
pulisher
May 22, 2025

Atara Biotherapeutics (NASDAQ:ATRA) & Turnstone Biologics (NASDAQ:TSBX) Financial Analysis - Defense World

May 22, 2025
pulisher
May 20, 2025

Top Executives at Atara Biotherapeutics Make Significant Stock Sales! - TipRanks

May 20, 2025
pulisher
May 20, 2025

Atara Biotherapeutics Executives Sell Shares for Tax Obligations - TradingView

May 20, 2025
pulisher
May 20, 2025

Citadel Advisors LLC Has $3.56 Million Position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA) - Defense World

May 20, 2025
pulisher
May 19, 2025

FDA Delivers Blow to ImmunityBio - Los Angeles Business Journal

May 19, 2025
pulisher
May 19, 2025

Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors - BioSpace

May 19, 2025
pulisher
May 18, 2025

Atara Biotherapeutics (ATRA) Expands Board Following $16 Million Offering | ATRA Stock News - GuruFocus

May 18, 2025
pulisher
May 17, 2025

Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors | ATRA Stock News - GuruFocus

May 17, 2025
pulisher
May 17, 2025

Atara Biotherapeutics Reports Strong Q1 2025 Results - TipRanks

May 17, 2025
pulisher
May 16, 2025

(ATRA) Investment Analysis and Advice - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Atara Biotherapeutics Announces $16M Stock Offering - TipRanks

May 16, 2025
pulisher
May 16, 2025

Atara Biotherapeutics First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Atara Biotherapeutics: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

Atara Biotherapeutics sets stock and warrant offering prices By Investing.com - Investing.com India

May 16, 2025

Atara Biotherapeutics Inc Stock (ATRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.88
price down icon 0.59%
$35.59
price up icon 0.34%
$102.56
price down icon 1.55%
$26.20
price down icon 5.18%
$110.02
price down icon 0.92%
biotechnology ONC
$294.55
price up icon 1.45%
Cap:     |  Volume (24h):